CIK: 0001281446 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $549,037 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| URGN | UROGEN PHARMA LTD | 2,620,545 | $36,714 | 6.7% | $16.05 | 0.0% | COM | M96088105 |
| — | ALPINE IMMUNE SCIENCES INC | 3,078,633 | $35,250 | 6.4% | $7.41 | — | COM | 02083G100 |
| PLRX | PLIANT THERAPEUTICS INC | 1,755,184 | $30,435 | 5.5% | $17.68 | -2.0% | COM | 729139105 |
| PCVX | VAXCYTE INC | 531,211 | $27,081 | 4.9% | $26.90 | +83.4% | COM | 92243G108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 727,426 | $25,933 | 4.7% | $41.00 | -3.4% | COM | 90400D108 |
| ALKS | ALKERMES PLC | 875,044 | $24,510 | 4.5% | $29.77 | -1.5% | SHS | G01767105 |
| — | RAPT THERAPEUTICS INC | 1,458,070 | $24,233 | 4.4% | $20.58 | — | COM | 75382E109 |
| ZURA | ZURA BIO LTD | 3,295,000 | $21,747 | 4.0% | $8.03 | -16.8% | CLASS A ORD SHS | G9TY5A101 |
| SRPT | SAREPTA THERAPEUTICS INC | 165,200 | $20,026 | 3.6% | $124.83 | -9.5% | COM | 803607100 |
| EOLS | EVOLUS INC | 2,186,934 | $19,989 | 3.6% | $8.90 | +0.8% | COM | 30052C107 |
| — | POINT BIOPHARMA GLOBAL INC | 2,909,960 | $19,409 | 3.5% | $7.55 | — | COM | 730541109 |
| CYTK | CYTOKINETICS INC | 600,000 | $17,676 | 3.2% | $40.16 | -17.1% | COM NEW | 23282W605 |
| XENE | XENON PHARMACEUTICALS INC | 500,001 | $17,080 | 3.1% | $22.27 | +68.0% | COM | 98420N105 |
| ANAB | ANAPTYSBIO INC | 894,333 | $16,062 | 2.9% | $23.96 | -20.4% | COM | 032724106 |
| IMCR | IMMUNOCORE HLDGS PLC | 290,917 | $15,099 | 2.8% | $50.92 | — | ADS | 45258D105 |
| — | AEROVATE THERAPEUTICS INC | 1,091,233 | $14,808 | 2.7% | $21.89 | — | COM | 008064107 |
| — | INTRA-CELLULAR THERAPIES INC | 225,000 | $11,720 | 2.1% | $52.09 | — | COM | 46116X101 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,691,768 | $11,589 | 2.1% | $12.61 | -32.2% | COM | 00461U105 |
| SRPT | SAREPTA THERAPEUTICS INC | 95,000 | $11,516 | 2.1% | $124.83 | -9.5% | Put | 803607100 |
| PTCT | PTC THERAPEUTICS INC | 500,000 | $11,205 | 2.0% | $37.19 | 0.0% | COM | 69366J200 |
| REPL | REPLIMUNE GROUP INC | 638,495 | $10,925 | 2.0% | $19.64 | 0.0% | COM | 76029N106 |
| — | OPTINOSE INC | 8,839,939 | $10,873 | 2.0% | $1.78 | — | COM | 68404V100 |
| FOLD | AMICUS THERAPEUTICS INC | 857,000 | $10,421 | 1.9% | $12.26 | +5.2% | COM | 03152W109 |
| ACLX | ARCELLX INC | 287,500 | $10,316 | 1.9% | $33.94 | +1.6% | COMMON STOCK | 03940C100 |
| — | KARUNA THERAPEUTICS INC | 60,500 | $10,230 | 1.9% | $169.09 | — | COM | 48576A100 |
| — | AKERO THERAPEUTICS INC | 198,500 | $10,040 | 1.8% | $50.58 | — | COM | 00973Y108 |
| INSM | INSMED INC | 394,872 | $9,971 | 1.8% | $22.87 | 0.0% | COM PAR $.01 | 457669307 |
| — | RENEO PHARMACEUTICALS INC | 1,167,061 | $8,887 | 1.6% | $6.58 | — | COM | 75974E103 |
| APGE | APOGEE THERAPEUTICS INC | 400,000 | $8,520 | 1.6% | $22.03 | 0.0% | COM | 03770N101 |
| GOSS | GOSSAMER BIO INC | 6,230,272 | $5,189 | 0.9% | $1.15 | 0.0% | COM | 38341P102 |
| — | IGM BIOSCIENCES INC | 615,317 | $5,138 | 0.9% | $9.07 | — | COM | 449585108 |
| HRTX | HERON THERAPEUTICS INC | 4,737,368 | $4,879 | 0.9% | $3.84 | -62.9% | COM | 427746102 |
| ACRS | ACLARIS THERAPEUTICS INC | 700,000 | $4,795 | 0.9% | $12.61 | -32.2% | Call | 00461U105 |
| — | CEREVEL THERAPEUTICS HLDNG I | 215,000 | $4,693 | 0.9% | $21.83 | — | COM | 15678U128 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 1,074,101 | $4,458 | 0.8% | $4.82 | +28.2% | COM | 00509G209 |
| — | GENERATION BIO CO | 1,022,537 | $3,875 | 0.7% | $5.04 | — | COM | 37148K100 |
| — | MIRATI THERAPEUTICS INC | 86,302 | $3,759 | 0.7% | $43.56 | — | COM | 60468T105 |
| TERN | TERNS PHARMACEUTICALS INC | 645,899 | $3,249 | 0.6% | $6.35 | 0.0% | COM | 880881107 |
| — | TALARIS THERAPEUTICS INC | 1,000,000 | $2,810 | 0.5% | $2.96 | — | COM | 87410C104 |
| — | GRACELL BIOTECHNOLOGIES INC | 579,667 | $1,669 | 0.3% | $2.26 | — | SPONSORED ADS | 38406L103 |
| SLDB | SOLID BIOSCIENCES INC | 450,403 | $1,135 | 0.2% | $5.77 | -32.7% | COM NEW | 83422E204 |
| — | AMBRX BIOPHARMA INC | 97,700 | $1,124 | 0.2% | — | — | Call | 02290A102 |